ZRP-24236-90357
2 vaccinations
1 coded response
9 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 327 / FL
- Registered
- 2021-06-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-05-12
Dose 1 — Pfizer-BioNTech
-
2021-06-03
Registered in v-safe
-
2021-06-03
Dose 2 — Pfizer-BioNTech
- 2021-06-03
-
2021-06-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-06-05
- 2021-06-07
- 2021-06-08
- 2021-06-09
- 2021-06-10
- 2021-06-17
-
2021-09-04
Survey response — 3 months, dose 2MedDRA: Chest discomfort, Cough, Nasal congestion, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Tightness of chest, cough, nasal and chest congestion lMedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-12 | Pfizer-BioNTech | |
| 2 | 2021-06-03 | Pfizer-BioNTech |
Free text
Release 9 — 3 months, dose 2
Symptoms: Tightness of chest, cough, nasal and chest congestion l
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest discomfort | ✓ | · | ✓ |
| SD | Cough | ✓ | · | ✓ |
| SD | Nasal congestion | ✓ | · | ✓ |
| SD | Respiratory tract congestion | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release